Skip to content

Optimization of Exercise Capacity in Elite Judokas: Effects of a High-intensity Hypoxic Training Program With Eccentric Overload and Effect of Gender.

Optimization of Exercise Capacity in Elite Judokas: Effects of a High-intensity Hypoxic Training Program With Eccentric Overload and Effect of Gender.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07778017
Acronym
HYPOXPERF JUDO
Enrollment
30
Registered
2026-08-21
Start date
2024-03-11
Completion date
2026-06-25
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Be a Member of the French Judo Federation

Brief summary

The main objective of this study is to evaluate the effects of an innovative training program on key factors affecting judo performance. This program includes high-intensity conventional cycling sessions in hypoxic conditions (simulated altitude), with or without eccentric cycling sequences. During this type of cycling, a motor drives the pedals in the opposite direction compared to conventional pedaling, and the participant is asked to try to slow down the movement of the bike's pedals (braking muscle actions). To this end, a 6-week training program consisting of 2 sessions per week will be proposed. The program's impact on the body and judo performance capacity will be assessed using a battery of tests administered before the program (pre-tests) and again at the end of the 6-week training program (post-tests). This information will contribute to the development of a new training strategy and, offer promising prospects for the development of new training methods. This study is part of the "Very High-Performance Sport" Priority Research Program from the French National Research Agency.

Interventions

OTHERHypoxia training

Training at a simulated altitude of 3000 m

OTHEREccentric cycling

Training at a simulated altitude of 3000 m and Eccentric cycling

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER
French National Research Agency
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 23 Years
Healthy volunteers
Yes

Inclusion criteria

Member of the male or female France Judo Training Centers or of the Strasbourg Judo Development Center Registered with the French Judo Federation Male or female aged between 16 and 23 years inclusive Female participants using effective contraception at inclusion and agreeing to maintain it throughout the study participation Willing to participate in the study Non-smoker or having stopped smoking for at least 5 years Affiliated with a health insurance social security scheme Subject (and holders of parental authority, if the subject is a minor) able to understand the objectives and risks related to the research and to provide dated and signed informed consent

Exclusion criteria

Recent muscular, tendinous, or joint disorders affecting the lower limbs (\<3 months) Neurological, respiratory, cardiovascular, or metabolic disorders Abnormality detected during the inclusion visit or during the maximal exercise test (pre-test no. 1) Ongoing drug treatment that cannot be discontinued 7 days before Day 0 (e.g., anti-inflammatory drugs) Pregnant (urine test at inclusion) or breastfeeding women Exposure to altitude (\>2000 m for more than 7 days) within the past 3 months Inability to understand the informed information provided (e.g., emergency situation, comprehension difficulties, etc.) Subject under legal protection measures, guardianship, or curatorship

Design outcomes

Primary

MeasureTime frame
The difference in maximal voluntary isometric strength of the extensor muscles measured on Day 3 and Day 57. Knee extensors of the right leg (newton-meters) Knee flexors of the right leg (newton-meters)Day 57.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORIrina ENACHE, MD

Hôpitaux Universitaires de Strasbourg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026